Joachim Rom

Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer

Charles E. Geyer, Judy E. Garber, Richard D. Gelber et al. · Annals of Oncology · 2022 · 404 citations · Full text

Breast Oncology, Overall Survival, Medicine +7

Metronomic cyclophosphamide treatment in metastasized breast cancer patients: immunological effects and clinical outcome

Yingzi Ge, Christoph Domschke, Natalija Stoiber et al. · Cancer Immunology Immunotherapy · 2011 · 222 citations · Full text

Immunological Effects, Clinical Outcome, Metronomic Cyclophosphamide Treatment +14

The cancer-associated microprotein CASIMO1 controls cell proliferation and interacts with squalene epoxidase modulating lipid droplet formation

Maria Polycarpou‐Schwarz, Matthias Groß, Pieter Mestdagh et al. · Oncogene · 2018 · 172 citations

Tumor Biology, Cancer-associated Microprotein Casimo1, Medicine +8

Genome‐wide methylation screen in low‐grade breast cancer identifies novel epigenetically altered genes as potential biomarkers for tumor diagnosis

Marta Faryna, Carolin Konermann, Sebastian Aulmann et al. · The FASEB Journal · 2012 · 89 citations · Full text

Evaluation of Virtual Touch Tissue Imaging Quantification, a New Shear Wave Velocity Imaging Method, for Breast Lesion Assessment by Ultrasound

Michael Golatta, Mirjam Schweitzer-Martin, Aba Harcos et al. · BioMed Research International · 2014 · 81 citations · Full text